Skip to main content
Clinical Trials/DRKS00031943
DRKS00031943
Completed
未知

on-invasive method for the treatment of internal nasal valve stenosis in endurance athletes

Klinik für HNO und Kopf- und Halschirurgie St. Elisabeth Hospital Universitätsklinikum der Ruhr-Universität Bochum0 sites25 target enrollmentAugust 16, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
Internal nasal valve stenosis
Sponsor
Klinik für HNO und Kopf- und Halschirurgie St. Elisabeth Hospital Universitätsklinikum der Ruhr-Universität Bochum
Enrollment
25
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
August 16, 2023
End Date
December 31, 2020
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Klinik für HNO und Kopf- und Halschirurgie St. Elisabeth Hospital Universitätsklinikum der Ruhr-Universität Bochum

Eligibility Criteria

Inclusion Criteria

  • 1\. The study participant understands the study procedures and agrees to participate by signing the consent form.
  • 2\. The study participant is male or female, at least 18 years of age.
  • 3\. The study participant must be healthy and free of clinically significant diseases that interfere with the study or procedures or affect its safety.
  • 4\. The study participants engage in endurance sports on a regular basis. This is defined by performing an endurance sport discipline, such as jogging, cycling, swimming, rowing, cross\-country skiing, or cross\-trainer for at least 30 minutes and at least 2 times a week consistently for the past 3 months.
  • 5\. The study participants complain of nasal airway obstruction when engaging in endurance sports.
  • 6\. The study participants suffer from functionally relevant nasal valve stenosis.

Exclusion Criteria

  • 1\. Study participants are excluded
  • a) With a cardiac pacemaker.
  • b) with a blood coagulation disorder.
  • c) with chronic obstructive pulmonary disease (COPD).
  • d) with bronchial asthma.
  • e) with a cardio\-vascular disease.
  • f) with joint arthrosis.
  • g) with immunosuppression after transplantation or HIV infection.
  • h) with an oncological disease.
  • i) with consumption of performance\-enhancing drugs.

Outcomes

Primary Outcomes

Not specified

Similar Trials